Rocket Doctor AI retains B2i Digital
Analysis based on 7 articles · First reported Aug 05, 2026 · Last updated Aug 05, 2026
The agreement is a minor corporate development for Rocket Doctor AI, Inc., potentially increasing its visibility among retail and institutional investors through B2i Digital's network of over 1.7 million market participants. The financial impact is limited to a modest cash fee, and the stock price impact is expected to be minimal.
Rocket Doctor AI, Inc. Inc., a Vancouver-based healthcare technology company listed on the Canadian Securities Exchange, entered into a digital advisory agreement with B2i Digital, Inc., a New York-based digital marketing firm. Under the agreement, B2i Digital will provide investor-focused marketing services including a featured company profile, paid advertising, content creation, social media distribution, email campaigns, and conference connections. The initial term is three months, with an option to extend to six or twelve months. Rocket Doctor AI, Inc. will pay B2i Digital a cash fee of $21,375 USD upon commencement, with additional fees for extensions. The agreement is subject to approval by the Canadian Securities Exchange. The collaboration aims to broaden Rocket Doctor AI, Inc.'s presence in the United States, particularly in New York, and to promote its AI-powered healthcare solutions.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard